CNTX logo

Context Therapeutics Inc.

CNTX
Healthcare|Biotechnology|US
$0.19
+0.01 (+2.98%)
DCF Value
$0.67
Tangible Book / Share
$0.40
Cash / Share
$0.45
Next Earnings Report
Nov 11, 2026
EPS est. -$0.09
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (2)

May 2028
Est. completion
P1Platinum-resistant Ovarian Cancer
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
NCT06515613n=156
Jan 2030
Est. completion
P1Triple Negative Breast Cancer (TNBC)
A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers
NCT07545122n=162

Recent Press Releases

Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202
Sep 9, 2026 · GlobeNewsWire

SEC Filings (72)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 5, 20268-KMaterial eventDocumentIndex
Aug 5, 202610-QQuarterly reportDocumentIndex
Jul 31, 20268-KMaterial eventDocumentIndex
Jul 31, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 27, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 26, 20268-KMaterial eventDocumentIndex
Jun 15, 20268-KMaterial eventDocumentIndex
May 18, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 12, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 8, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 6, 202610-QQuarterly reportDocumentIndex
May 1, 20268-KMaterial eventDocumentIndex
Apr 28, 2026ARSAnnual report to holdersDocumentIndex
Apr 28, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 28, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 17, 2026PRE 14AProxy / shareholder voteDocumentIndex
Apr 2, 20268-KMaterial eventDocumentIndex
Mar 23, 2026S-8Employee stock planDocumentIndex
Mar 23, 20268-KMaterial eventDocumentIndex
Mar 23, 202610-KAnnual reportDocumentIndex
Mar 13, 20268-KMaterial eventDocumentIndex
Feb 27, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 3, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 8, 20268-KMaterial eventDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 5, 20258-KMaterial eventDocumentIndex
Nov 5, 202510-QQuarterly reportDocumentIndex
Oct 24, 20258-KMaterial eventDocumentIndex
Oct 24, 2025424B5Offering prospectusDocumentIndex
Oct 20, 20258-KMaterial eventDocumentIndex
Sep 2, 20258-KMaterial eventDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex